Ice Bath in a Backpack: Cryogenx Secures $1.9M Seed Funding to Revolutionize Heatstroke Treatment

Cryogenx, a pioneering technology company devoted to helping people thrive in a warming world, is thrilled to announce the successful raise of $1,900,000. This substantial infusion of capital underscores the confidence that investors have in our groundbreaking approach and commitment to combating the escalating effects of global heat stress. At Cryogenx, our mission is clear: to design and manufacture innovative technology that empowers individuals to adapt and live safely on an increasingly hotter planet. Our flagship product, the Cryogenx CGX1, is a portable, on-demand body cooling device that promises to revolutionize heatstroke treatment. Often described as the "ice bath in your backpack," the CGX1 is engineered to simulate the benefits of ice water immersion while being far more accessible and resource-efficient. This device is specifically designed to provide life-saving cooling interventions in any setting, ensuring rapid response in critical situations. With global economic losses due to heat stress projected to reach $2.4 trillion annually by 2030 and heat-related deaths surging by an alarming 257%, our technology is more essential than ever. The recent funding will be pivotal in advancing our research, improving production scalability, and expanding our market reach so that the life-saving benefits of the CGX1 can be delivered to more communities globally. We believe that through innovative solutions and relentless dedication, we can mitigate the dangerous impacts of rising temperatures and create a safer, more sustainable future for all. This announcement marks a crucial milestone on our journey, and we look forward to accelerating our efforts to redefine emergency cooling treatment worldwide.